Search Result "FKBP12.6. K201"
Pharmacological Characteristics and Clinical Applications of K201
Journal: Current Clinical Pharmacology
Volume: 4 Issue: 2 Year: 2009 Page: 126-131
Author(s): Noboru Kaneko, Ryuko Matsuda, Yoshihito Hata, Ken Shimamoto
Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 2 Issue: 2 Year: 2007 Page: 110-118
Author(s): Rikuo Ochi, Sachin A. Gupte
Calcium Store Stability as an Antiarrhythmic Endpoint
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 8 Year: 2015 Page: 1053-1061
Author(s): Antonio Zaza, Marcella Rocchetti
Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 3195-3211
Author(s): Christopher H. George, F. Anthony Lai
Targeting Cardiomyocyte Ca2+ Homeostasis in Heart Failure
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 4 Year: 2015 Page: 431-448
Author(s): Asmund T. Roe, Michael Frisk, William E. Louch
The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Journal: Current Molecular Pharmacology
Volume: 9 Issue: 2 Year: 2016 Page: 165-179
Author(s): Lana McClements,Stephanie Annett,Anita Yakkundi,Tracy Robson
Calcium Homeostasis and Kinetics in Heart Failure
Journal: Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2016 Page: 151-161
Author(s): Periklis A. Davlouros,Vasileios Gkizas,Chrysoula Vogiatzi,Georgios Giannopoulos,Dimitrios Alexopoulos,Spyridon Deftereos
Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 0 Year: 2021 Page: 1-11
Author(s): Mathilde Beaufils,Lauriane Travard,John Rendu,Isabelle Marty
Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets â Part II)
Journal: Current Molecular Pharmacology
Volume: 9 Issue: 2 Year: 2016 Page: 97-180
Author(s): Mario D. Galigniana